Skip to content
BALCAO · PHARMACEUTICAL PREPARATIONS · SMALL CAP

Bio-path Holdings, Inc. BPTH

15 fiscal years on record · USD · FY2024 reported · SEC filings only
$-9.9M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

·
Revenue, FY2024 · full 15-year series below
Revenue $M Net income $M
FY2018 · Revenue 0.0 · Net income -8.6
-4M-8M
201020132016201920222024
Compound annual growth
3 yrs
5 yrs
10 yrs
15 yrs

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

·
Operating margin Net margin
FY2017 · Operating -24232.4%
-20000%-40000%
201020172024
ROE
FY2024 · ROE -3325.7%
-1000%-2000%-3000%
201020172024
Three returns, three denominators.

Each USD of equity lost 3326 cents this year.

Cash & shareholders

·
returned in FY2024 · dividends + net buybacks
Free cash flow $M
FY2022 · FCF -15.1
-10M-20M
201020172024

Total assetsUSD 3.9M
EquityUSD 154,000.00
CashUSD 1.2M
Current ratio1.15×

Equity funds 4% of total assets.

The 15-year record

15 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
BPTH, 15-year financial record
Metric 202420232022202120202019201820172016201520142013201220112010
Revenue $B◌◌◌◌◌◌0.00.00.00.00.00.00.00.0◌
Operating income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0◌◌
Income tax $B0.00.00.00.00.00.00.00.00.00.00.00.00.00.0◌
Net income $B−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0
Free cash flow $B◌◌−0.0−0.0◌−0.0−0.0−0.0−0.0−0.0−0.0−0.0−0.0◌◌
EPS, diluted $−4.12−33.63−38.12−1.55−2.83−3.24−14.38−15.99−0.73−0.06−0.05−0.05−0.04−0.04−0.04
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————————
ROE %−3325.7−220.0−70.0−51.5−60.2−77.1−184.9−86.1−74.8−44.2−45.9−96.1−104.8−81.8−72.7
Shares out B0.010.000.010.010.000.000.000.000.000.090.090.080.060.060.05

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 61 reconciliationsAUDITED

Reconciled in 15 of the 15 fiscal years we could check. Six checks were skipped: the balance sheet is not tagged before 2010. Four checks were skipped: the share count is not tagged before 2011.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPharmaceutical Preparations
Listed onOTC market
Incorporated inWyoming
Fiscal year endsDecember 31
SEC categorysmaller reporting company
Data on record since2007

Share this section

Download image